Literature DB >> 15709038

Alternative tRNA priming of human immunodeficiency virus type 1 reverse transcription explains sequence variation in the primer-binding site that has been attributed to APOBEC3G activity.

Atze T Das1, Monique Vink, Ben Berkhout.   

Abstract

It is generally assumed that human immunodeficiency virus type 1 (HIV-1) uses exclusively the cellular tRNA(3)(Lys) molecule as a primer for reverse transcription. We demonstrate that HIV-1 uses not only tRNA(3)(Lys) but also an alternative tRNA primer. This tRNA was termed tRNA(5)(Lys), and the near completion of the human genome project has allowed the identification of four tRNA(5)(Lys)encoding genes. Priming with tRNA(5)(Lys) results in a single nucleotide polymorphism in the viral primer-binding site that is present in multiple natural and laboratory HIV isolates. This sequence variation was recently attributed to APOBEC3G activity. However, our results show that alternative tRNA priming can cause this mutation in the absence of APOBEC3G.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709038      PMCID: PMC548477          DOI: 10.1128/JVI.79.5.3179-3181.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

2.  Variable tRNA content in HIV-1IIIB.

Authors:  M Jiang; J Mak; M A Wainberg; M A Parniak; E Cohen; L Kleiman
Journal:  Biochem Biophys Res Commun       Date:  1992-06-30       Impact factor: 3.575

3.  The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle.

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

4.  Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations.

Authors:  B Berwin; E Barklis
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

5.  A nucleotide substitution in the tRNA(Lys) primer binding site dramatically increases replication of recombinant simian immunodeficiency virus containing a human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Kelly Soderberg; Lynn Denekamp; Sarah Nikiforow; Karen Sautter; Ronald C Desrosiers; Louis Alexander
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 6.  tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1.

Authors:  Lawrence Kleiman
Journal:  IUBMB Life       Date:  2002-02       Impact factor: 3.885

7.  Initiation of HIV-1 reverse transcription is regulated by a primer activation signal.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

8.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

9.  Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1.

Authors:  M Jiang; J Mak; A Ladha; E Cohen; M Klein; B Rovinski; L Kleiman
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Forced selection of a human immunodeficiency virus type 1 variant that uses a non-self tRNA primer for reverse transcription: involvement of viral RNA sequences and the reverse transcriptase enzyme.

Authors:  Truus E M Abbink; Nancy Beerens; Ben Berkhout
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more
  9 in total

1.  An extended stem-loop 1 is necessary for human immunodeficiency virus type 2 replication and affects genomic RNA encapsidation.

Authors:  Jean-Marc Lanchy; J Stephen Lodmell
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.

Authors:  Zhen Wang; Wenzhou Wang; Ya Cheng Cui; Qinghua Pan; Weijun Zhu; Patrick Gendron; Fei Guo; Shan Cen; Michael Witcher; Chen Liang
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

3.  Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site.

Authors:  Scott R Eberhardy; Joao Goncalves; Sofia Coelho; David J Segal; Ben Berkhout; Carlos F Barbas
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  Initiation of HIV Reverse Transcription.

Authors:  Catherine Isel; Chantal Ehresmann; Roland Marquet
Journal:  Viruses       Date:  2010-01-18       Impact factor: 5.818

5.  New insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3.

Authors:  Chengxiang Wu; Vivek R Nerurkar; Yuanan Lu
Journal:  Retrovirology       Date:  2013-10-24       Impact factor: 4.602

6.  HIV-1 Subtypes and 5'LTR-Leader Sequence Variants Correlate with Seroconversion Status in Pumwani Sex Worker Cohort.

Authors:  Raghavan Sampathkumar; Joel Scott-Herridge; Binhua Liang; Joshua Kimani; Francis A Plummer; Ma Luo
Journal:  Viruses       Date:  2017-12-23       Impact factor: 5.048

7.  Low-level alternative tRNA priming of reverse transcription of HIV-1 and SIV in vivo.

Authors:  Christine M Fennessey; Celine Camus; Taina T Immonen; Carolyn Reid; Frank Maldarelli; Jeffrey D Lifson; Brandon F Keele
Journal:  Retrovirology       Date:  2019-04-04       Impact factor: 4.602

8.  On the primer binding site mutation that appears and disappears during HIV and SIV replication.

Authors:  Ben Berkhout; Atze T Das
Journal:  Retrovirology       Date:  2015-08-25       Impact factor: 4.602

9.  Analysis of Simian Endogenous Retrovirus (SERV) Full-Length Proviruses in Old World Monkey Genomes.

Authors:  Antoinette C van der Kuyl
Journal:  Genes (Basel)       Date:  2022-01-10       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.